The relevance of serum macrophage migratory inhibitory factor and cognitive dysfunction in patients with cerebral
Jianhua Zhao1, Xiaoting Wang1, Qiong Li1
1Henan Joint International Research Laboratory of Neurorestoratology for Senile Dementia, Henan Key Laboratory of Neurorestoratology, Department of Neurology, First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China.
Insights
Cerebral small vascular disease (CSVD) is a growing health concern. Macrophage migration inhibitory factor (MIF) may play a key role in CSVD development and offers potential protection against vascular cognitive impairment (VCI).
Area of Science:
- Neurology
- Vascular Biology
- Immunology
Background:
- Cerebral small vascular disease (CSVD) is a prevalent cerebrovascular condition and a leading cause of vascular cognitive impairment (VCI) and stroke.
- The increasing prevalence of risk factors like hypertension and population aging contribute to a rising disease burden.
- Current understanding of CSVD pathophysiology is limited, hindering the development of effective preventive and therapeutic strategies.
Purpose of the Study:
- To review the role of macrophage migration inhibitory factor (MIF) in the pathogenesis of CSVD and VCI.
- To explore MIF's involvement in chronic cerebral ischemia-hypoperfusion and neurodegeneration.
- To present new evidence linking MIF to CSVD and its potential protective effects against VCI.
Main Methods:
- Literature review of studies on MIF, CSVD, VCI, chronic cerebral ischemia-hypoperfusion, and neurodegeneration.
- Analysis of existing evidence regarding MIF's function as a multifunctional cytokine in vascular dysfunction.
- Synthesis of new findings on MIF's role in CSVD pathology.
Main Results:
- MIF is implicated in the development of vascular dysfunction diseases.
- Evidence suggests MIF contributes to the pathogenesis of CSVD and VCI.
- MIF may offer protective mechanisms against VCI.
Conclusions:
- MIF is a potential therapeutic target for CSVD and VCI.
- Further research into MIF's role could lead to novel treatment strategies for these debilitating conditions.
- Understanding MIF's mechanisms is crucial for combating the growing burden of CSVD and VCI.
Abstract:
Cerebral small vascular disease (CSVD) is a common type of cerebrovascular disease, and an important cause of vascular cognitive impairment (VCI) and stroke. The disease burden is expected to increase further as a result of population aging, an ongoing high prevalence of risk factors (e.g., hypertension), and inadequate management. Due to the poor understanding of pathophysiology in CSVD, there is no effective preventive or therapeutic approach for CSVD. Macrophage migration inhibitory factor (MIF) is a multifunctional cytokine that is related to the occurrence and development of vascular dysfunction diseases. Therefore, MIF may contribute to the pathogenesis of CSVD and VCI. Here, reviewed MIF participation in chronic cerebral ischemia-hypoperfusion and neurodegeneration pathology, including new evidence for CSVD, and its potential role in protection against VCI.
